Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 96604-21-6
2. Pyridin-2-yl(7-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl)methanone
3. Pyridin-2-yl-[7-pyridin-4-yl-pyrazole[1,5-a]pyrimidin-3-yl]methanone
4. Pyridin-2-yl-(7-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)methanone
5. Cl-273547
6. 2h6kvc5e76
7. Cl 273,547
8. 2-pyridyl 7-(4-pyridyl)pyrazolo(1,5-a)pyrimidin-3-yl Ketone
9. 2-pyridinyl(7-(4-pyridinyl)pyrazolo(1,5-a)pyrimidin-3-yl)methanone
10. Methanone, 2-pyridinyl(7-(4-pyridinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-
11. Methanone, 2-pyri(dinyl(7-(4-pyridinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-
12. Ocinaplon [usan:inn]
13. Methanone, 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-
14. Cl 273547
15. Ocinaplon (usan/inn)
16. Unii-2h6kvc5e76
17. 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]methanone
18. Ocinaplon [inn]
19. Ocinaplon [usan]
20. Schembl122652
21. Gtpl4277
22. Zinc5014
23. Chembl2105199
24. Dtxsid00242362
25. Wda60421
26. Akos024458146
27. Cs-w001692
28. Db06529
29. Hy-w001692
30. Ncgc00370957-01
31. As-72567
32. Ft-0762986
33. D02617
34. Q2013712
35. 4-[3-(pyridine-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]pyridine
36. 4-{3-[(pyridin-2-yl)carbonyl]pyrazolo[1,5-a]pyrimidin-7-yl}pyridine
37. Methanone,2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-
| Molecular Weight | 301.30 g/mol |
|---|---|
| Molecular Formula | C17H11N5O |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 301.09635999 g/mol |
| Monoisotopic Mass | 301.09635999 g/mol |
| Topological Polar Surface Area | 73 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 425 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in anxiety disorders.
ABOUT THIS PAGE
73
PharmaCompass offers a list of Ocinaplon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ocinaplon manufacturer or Ocinaplon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ocinaplon manufacturer or Ocinaplon supplier.
PharmaCompass also assists you with knowing the Ocinaplon API Price utilized in the formulation of products. Ocinaplon API Price is not always fixed or binding as the Ocinaplon Price is obtained through a variety of data sources. The Ocinaplon Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ocinaplon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ocinaplon, including repackagers and relabelers. The FDA regulates Ocinaplon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ocinaplon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ocinaplon supplier is an individual or a company that provides Ocinaplon active pharmaceutical ingredient (API) or Ocinaplon finished formulations upon request. The Ocinaplon suppliers may include Ocinaplon API manufacturers, exporters, distributors and traders.
Ocinaplon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ocinaplon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ocinaplon GMP manufacturer or Ocinaplon GMP API supplier for your needs.
A Ocinaplon CoA (Certificate of Analysis) is a formal document that attests to Ocinaplon's compliance with Ocinaplon specifications and serves as a tool for batch-level quality control.
Ocinaplon CoA mostly includes findings from lab analyses of a specific batch. For each Ocinaplon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ocinaplon may be tested according to a variety of international standards, such as European Pharmacopoeia (Ocinaplon EP), Ocinaplon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ocinaplon USP).
